The immune system is one of the most sensitive targets of PFAS toxicity. Research consistently shows that PFAS exposure suppresses immune function in ways that reduce the body’s ability to fight infections, respond to vaccines, and defend against cancer. These immunotoxic effects have become a central concern in PFAS health research.
PFAS as Immunotoxicants
PFAS compounds have been shown to alter the development and function of multiple immune cell types. They reduce the number and activity of natural killer (NK) cells, which are critical for recognizing and destroying virus-infected and tumor cells. PFAS also affect T cell and B cell populations, impairing both cellular and humoral immune responses.
The immunotoxic effects of PFAS appear to operate through several mechanisms, including activation of nuclear receptors that regulate immune gene expression, disruption of cytokine signaling, and alteration of thymic development. The thymus, where T cells mature, may be particularly sensitive to PFAS effects during childhood.
Vaccine Response Impairment
Perhaps the most clinically significant immune finding is that PFAS exposure impairs vaccine-induced immunity. A landmark Faroe Islands birth cohort study found that children with higher PFAS blood levels produced significantly fewer antibodies following routine childhood vaccinations, including diphtheria and tetanus vaccines. The effect was dose-dependent and remained significant even at relatively low exposure levels.
Similar findings have been replicated in multiple countries. A study of Danish children found that PFAS exposure was associated with a 25–50% reduction in vaccine antibody titers for several common childhood vaccines. This level of immune suppression could meaningfully reduce the protection conferred by vaccination, with implications for both individual and community health.
Increased Infection Susceptibility
Beyond vaccine response, PFAS-exposed individuals show increased susceptibility to common infections. Studies have found higher rates of upper respiratory infections, otitis media (ear infections), and other infectious illnesses in children with elevated PFAS exposures. Adults with high PFAS levels have also shown evidence of impaired immune responses to respiratory pathogens.
Research during the COVID-19 pandemic suggested that communities with higher PFAS contamination may have experienced more severe outcomes, though confounding factors make these associations difficult to interpret definitively.
Reducing Immunotoxic Exposure Through Filtration
For families with young children — who are most vulnerable to vaccine impairment and infection susceptibility — reducing PFAS exposure through water filtration is particularly important. Reverse osmosis systems remove the vast majority of PFAS from drinking water and represent the most effective point-of-use technology available.
Given the dose-dependent nature of PFAS immunotoxicity, even partial reductions in exposure may be meaningful. Testing household water for PFAS and implementing appropriate filtration based on measured contamination levels provides the most targeted approach to reducing immune system risks.